Drug lookup
Drug reference

typhoid-ty21a vaccine

Live attenuated bacterial vaccine · Vaccine for typhoid

Live attenuated bacterial vaccineVaccine for typhoid
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

This live oral vaccine is prepared from the Ty 21a attenuated strain of S. typhi, which lacks the Vi polysaccharide and is nonpathogenic. It works by lodging in the intestinal mucosa to protect against S. typhi invasion of the gut and also provides systemic immunity, producing high cell-mediated and modest antibody-mediated immunity.

Indications

Protection against S. typhi invasion of the gutSystemic immunity against S. typhi

Dosing

Adult
3 doses on alternate days in the form of enteric coated capsules, taken between meals.
Pediatric
3 doses on alternate days in the form of enteric coated capsules, taken between meals. Not approved for children below 5 years.

Pharmacokinetics

Duration
3 years

Contraindications

  • Children below 5 years
  • Pregnant women

Side effects

Common
Diarrhoea (2% cases)Abdominal pain (2% cases)Rashes (2% cases)

Related guidelines

Other Live attenuated bacterial vaccine drugs

Ask House about typhoid-ty21a vaccine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team